Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ELBIT MEDICAL IMAGING - EMITF - U.S. OTC -- Ignore unavailable to you. Want to Upgrade?

To: voodooist who wrote (72)	9/13/1998 12:10:00 PM
From: MUDMAN	Read Replies (1) \| Respond to of 79

According to the Taipan Hotline, (released Friday after the transaction announcement), which follows closely this whole play (all the Elron related companies), the transaction is worth approximately $375mm. Some of these monies will go to taxes and other restructuring charges. Taipan expects this to cause a rise in EMITF' share price, since EMITF owns +- 58% of Elscint. They advise selling EMITF should EMITF approach $14 - a level which they characterize as fully valued. Mudman